JOHNSON & JOHNSON MEDICAL financials
A multi-period view of the public annual-account figures reported for JOHNSON & JOHNSON MEDICAL, with comparable measures and links to available source documents.
Company overviewRegistry number
0425967580
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for JOHNSON & JOHNSON MEDICAL
2025 versus 2024
- Operating line
- €330,019,973
- EBITDA
- €12,947,561
- Total assets
- €225,600,003
- Equity
- €80,168,292
+0.1%
+2.9%
+13.3%
+14.6%
EBITDA margin +3.9% · Equity ratio +35.5%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €330,019,973 | €12,947,561 | €225,600,003 | €80,168,292 | - |
| 202431 Dec 2024 | €329,692,902 | €12,579,353 | €199,068,206 | €69,948,244 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.